Skip to main content

Third Wave Adds Clinical Genetics Execs; Deltagen Hires R&D VP

NEW YORK, June 5 - Third Wave Technologies said today that it had hired two new executives to pump up its clinical genetic testing services division.


The company appointed Donagh McCarthy senior vice president and general manager of the clinical business unit. McCarthy was most recently CEO of Protiveris, a private proteomics company, and general manager of Bacter's Renal division.


Third Wave also hired Jake Orville as sales director for the division. He was most recently national sales manager at SIMS Portex, which manufactures medical products.


Third Wave, based in Madison, Wis., develops, produces and markets genetic analysis products.



Gaithersburg, Md.-based Psychiatric Genomics said on June 4 that it had retained Bradley Lorimier as a director and business development consultant.


Lorimier was senior vice president for business development at Human Genome Sciences until 1997, when he retired.


Psychiatric Genomics develops treatments for mental illness by searching for gene-expression patterns associated with psychiatric disease.



Deltagen said on May 31 that Geoffrey Yarranton had joined the company as executive vice president of R&D.


Yarranton will guide drug discovery efforts toward clinical trials and direct the integration of the company's discovery projects.


Yarranton was previously senior vice president for R&D at Coulter, and became head of the South San Francisco site after the company's merger with Corixa. Before that he was in research at Celltech.


Deltagen also said that Peter Myers, executive vice president of subsidiary Deltagen Research Laboratories, had resigned. Deltagen acquired this division from Bristol-Myers Squibb in February 2002



Bangalore bioinformatics startup Molecular Connections has added Eitan Rubin to its scientific advisory board, the firm said on May 25.


Eitan, previously at Compugen, is now head of the bioinformatics and biological computing unit at the Weizmann Institute of Science in Rehovot, Israel.


He joins Rockefeller University plant molecular biologist Nam-Hai Chua on the board.


Molecular Connections was founded last August as a joint venture between a health-care incubator and the Lab for Information Technology, a Singaporean national research institute.



Geert Wenes has joined the National Center for Genome Resources as program leader for bioinformatics, the institute said on May 29.


Wenes, a physics and high-performance computing expert, will direct new initiatives in bioinformatics and computational biology.


Wenes was previously involved in IBM's Life Sciences division, where he managed the technical support center for the company's life sciences and bioinformatics units.


His academic training is in theoretical physics, and he did post-doc work at Los Alamos National Laboratory and at the Dutch Nuclear Physics Accelerator Institute.


The National Center for Genome Resources is a nonprofit institute focused on systems biology, computational biology, and bioinformatics.



Caliper Technologies said on May 22 that it had named William Kruka vice president of business development.


Kruka will broaden the market for Caliper's microfluidics products and systems, and promote the company's growth and development.


He was most recently senior manager of business development at Applied Biosystems, where he led proteomics initiatives, including mass spectrometry, chromatography and microfluidics.


He reports to Vice President of Corporate Development Michael Knapp, who is scheduled to become CEO on July 1, 2002.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kat McGowan at
[email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics that runs every Wednesday.
The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.